A molecular revolution in uveal melanoma: implications for patient care and targeted therapy
about
Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)Recent developments in prognostic and predictive testing in uveal melanomaThe genetics of uveal melanoma: current insightsComprehensive review of BAP1 tumor predisposition syndrome with report of two new casesEstablishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasisPRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012)Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012)The impact of sequencing on diagnosis and treatment of malignant melanoma.Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma.Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.Assessing Prognosis in Uveal Melanoma.Gene of the month: BAP1.Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma.Low thyroid hormone levels improve survival in murine model for ocular melanomaDiagnostic value of SOX-10 immunohistochemical staining for the detection of uveal melanoma.Punctuated evolution of canonical genomic aberrations in uveal melanoma.Histopathologic and mutational analysis of a case of blue nevus-like melanoma.Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma.
P2860
Q26770492-057922CC-3AAD-4D6E-A9FA-4A5243264121Q26824096-615F8579-F4D3-42CF-833F-9DE1F7F9D0F2Q28073150-A764FC81-A839-4EE0-B031-B4A219C9CB57Q28397229-D006CF93-69A5-4E93-AD67-D08E49BBDA25Q33827461-2C0F25CE-E994-441B-BE97-0C242EE32DF6Q36658116-BEE9F191-4590-4456-B24A-B6C1A7FD24ECQ37381397-434C849C-A9BE-49FF-8C78-164A2DEF8E77Q37573466-299F5A5E-389C-48B1-868E-84D07A132A8CQ38715265-7D1F877A-1E4A-4A57-A134-431B40839F58Q38718726-9BE1C3DA-1BD1-4ED0-ACBE-FD19EB96A122Q38810854-64985842-01FD-4ED0-9A6A-245EC8D653EBQ38842906-C7227D6F-6E5D-492B-BFA1-C509B01E33FAQ38846801-AA94D31D-096A-4BFD-B5C3-0314B7FDFDB0Q39145837-060900EB-24CA-4085-91B8-3C2CFD6A5AD0Q41626926-F0649E9E-BCDD-422A-B54A-916F7CB40C09Q42139416-967C0F5E-FBBF-470E-AF89-9F6C8F9E42DAQ48276701-401EFABC-955F-4EA6-83F4-CF8A74A87BF3Q50202206-69F8C669-AD13-40C5-A207-FF4CE61E7F6EQ55455186-D7A5A1C0-C8FC-4A17-B53F-045669477E92
P2860
A molecular revolution in uveal melanoma: implications for patient care and targeted therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
A molecular revolution in uvea ...... ient care and targeted therapy
@ast
A molecular revolution in uvea ...... ient care and targeted therapy
@en
type
label
A molecular revolution in uvea ...... ient care and targeted therapy
@ast
A molecular revolution in uvea ...... ient care and targeted therapy
@en
prefLabel
A molecular revolution in uvea ...... ient care and targeted therapy
@ast
A molecular revolution in uvea ...... ient care and targeted therapy
@en
P2860
P1433
P1476
A molecular revolution in uvea ...... ient care and targeted therapy
@en
P2093
Daniel L Chao
P2860
P304
P356
10.1016/J.OPHTHA.2013.12.014
P577
2014-01-28T00:00:00Z